Here at East Genomics we support 16 Genomics Communities of Practice across cancers and rare and inherited conditions. In 2025 we ran over 120 sessions attended by over 1,500 healthcare staff across our region. Our series continues in 2026...
Below you can find out more about some upcoming Genomics CoP sessions, including links to register.
Tues 21 April: Lung Cancer
Topic: Updates from ESMO European Lung Cancer Congress
Speaker: Dr Jason Adhikaree, Clinical Associate Professor and Honorary Consultant Medical Oncologist, University of Nottingham
Thurs 23 April: Paediatric
Topic: Using AI tools to simplify the genomic test ordering process
Learn and practice:
- Extracting HPO terms from your clinic letters
- Selecting a test from the test directory with AI
Come prepared for a hands-on guided workshop aimed at saving you time and increasing the accuracy of your test orders
Guest Speaker: Ajoy Sarkar, Consultant in Clinical Genetics, Nottingham University Hospitals
Fri 24 April: Ophthalmology
Topic: Genetic Testing and Advances in Paediatric Glaucoma
- Development of the anterior segment of the eye and key genes involved at different stages
- Paediatric glaucoma - definition, key clinical features and classification
- Genetic causes of primary congenital and juvenile glaucoma, and associated features
- Overview of management of paediatric glaucoma
Speaker: Dr Nicola Cronbach, PhD researcher and Ophthalmology registrar UCL and Moorfields Eye Hospital
Mon 27 April: Paediatric Endocrinology
Topic: Beckwith-Wiedemann Syndrome and Multi-locus Imprinting Disorder
- Clinical and molecular aspects of Beckwith Weidemann syndrome
- Testing pathway and Management guidelines
- Case scenarios
- An introduction to MLID
Speaker: Dr Vijaya Ramakumaran, Clinical Geneticist, University Hospitals of Leicester
Thurs 7 May: Cancer of Unknown Primary
Topic: Orthopaedic approaches to patients who present with bone-only metastases as CUP
- Update on metastatic bone disease in UK
- What is the pathway for bone CUPs presenting with and without pathological fractures?
- Why do we biopsy?
- What might be the role for WGS/NGS in these cases?
- How do we manage patients with solitary bone tumours?
Speaker: Mr Jonathan Stevenson, Consultant Orthopaedic Oncology & Arthroplasty Surgeon, Clinical Lead for Genomics and Metastatic Bone Disease, Royal Orthopaedic Hospital NHS Trust
Fri 22 May: Gynaecological Oncology
Topic: Lynch VR module written about an Endometrial Patient
Speaker: Liz Lawrence, Programme Lead - Regional Genomic Clinical Practitioner Service, East of England Cancer Alliance
